Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 06 - 21 tags : Disease save search
Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2022-06-21 (Crawled : 16:00) - biospace.com/
RGLS | $2.23 -1.33% -1.35% 92K
|
Health Technology
|
| O: 3.45%
H: 0.0%
C: 0.0%
rgls8429 treatment fda designation drug disease kidney therapeutics
Gilead to Present Latest Data From Across Liver Disease Development Programs at the International Liver Congress™ 2022
Published: 2022-06-21 (Crawled : 14:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 1.34%
H: 0.0%
C: 0.0%
liver disease international
Cyclo Therapeutics to Present at the 2022 NPC Patient and Family Conference Hosted by the Australian NPC Disease Foundation
Published: 2022-06-21 (Crawled : 13:20) - biospace.com/
CYTH | $1.21 7.94% 21K
|
Professional, Scientific, and T...
|
| O: -2.68%
H: 0.0%
C: 0.0%
conference disease therapeutics
9 Meters Biopharma Announces Interim Analysis of Phase 3 Study of Larazotide for Celiac Disease Does Not Support Trial Continuation
Published: 2022-06-21 (Crawled : 13:00) - biospace.com/
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: -53.55%
H: 0.0%
C: 0.0%
biopharma disease trial phase 3
ANI Pharmaceuticals Adopts Veeva Commercial Cloud to Better Support Rare Disease Patients
Published: 2022-06-21 (Crawled : 12:00) - biospace.com/
VEEV | $200.52 -0.29% -0.26% 540K
|
Technology Services
|
| O: 4.75%
H: 0.0%
C: 0.0%
ANIP S | $65.375 -1.16% -1.17% 83K
|
Health Technology
|
| O: 2.34%
H: 0.0%
C: 0.0%
rare disease commercial cloud
Ocugen Announces Publication of Positive Results of COVID-19 Vaccine Trial for Children 2-18 in The Lancet Infectious Diseases
Published: 2022-06-21 (Crawled : 12:00) - biospace.com/
OCGN | News 4 | $1.17 -6.4% -6.84% 7.3M
|
Health Technology
|
| O: 10.89%
H: 0.0%
C: 0.0%
covid-19 children vaccine lancet trial positive publication disease
SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
Published: 2022-06-21 (Crawled : 11:00) - biospace.com/
SQZ | $0.435 0.0% 30M
|
Health Technology
|
| O: 2.92%
H: 0.0%
C: 0.0%
disease preclinical sqz immunology meeting pre-clinical
Emergent BioSolutions Announces Publication of CHIKV VLP Phase 2 Safety and Immunogenicity Data in The Lancet Infectious Diseases
Published: 2022-06-21 (Crawled : 11:00) - globenewswire.com
EBS | News | $2.18 -4.8% 0.0% 800K
|
Health Technology
|
| O: 5.29%
H: 0.0%
C: 0.0%
lancet publication chikungunya disease phase 2
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.